These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 5031856)

  • 1. Changes in breast size during prolonged use of contraceptive injections.
    McDaniel EB; Pardthaisong T
    J Med Assoc Thai; 1972 May; 55(5):294-7. PubMed ID: 5031856
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of medroxyprogesterone acetate employed as a long-term injectable contraceptive.
    Ringrose CA
    J Reprod Med; 1972 Feb; 8(2):75-9. PubMed ID: 4666624
    [No Abstract]   [Full Text] [Related]  

  • 3. [Long-acting gestagen injections as a contraceptive agent].
    Jeppsson S
    Lakartidningen; 1972 Mar; 69(11):1245-51. PubMed ID: 5021325
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical aspects on the use of medroxyprogesterone injections as a contraceptive agent].
    de Sampalo Júnior LF; Neme B; Dantas ML; Santos AM; Scarpelli SA
    Matern Infanc (Sao Paulo); 1974; 33(2):235-40. PubMed ID: 4478846
    [No Abstract]   [Full Text] [Related]  

  • 5. [Depot medroxyprogesterone acetate as contraceptive agent].
    Duarte-Contreras A
    Rev Colomb Obstet Ginecol; 1973; 24(1):13-9. PubMed ID: 4804874
    [No Abstract]   [Full Text] [Related]  

  • 6. Ethinyl estradiol and medroxyprogesterone treatment in advanced breast cancer: a pilot study.
    Pellegrini A; Massidda B; Mascia V; Ionta MT; Lippi MG; Muggiano A; Carboni E; Robustelli della Cuna G; Bernardo G; Strada MR; Pavesi L
    Cancer Treat Rep; 1981; 65(1-2):135-6. PubMed ID: 7226163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experiences with a 3-monthly injections of medroxyprogesterone acetate (MPA) as a contraceptive agent].
    Linthorst G; Wibaut EP; de Jongh RE
    Ned Tijdschr Geneeskd; 1972 Sep; 116(38):1694-8. PubMed ID: 5069858
    [No Abstract]   [Full Text] [Related]  

  • 8. Depo-medroxyprogesterone acetate as a contraceptive.
    Seymour RJ; Powell LC
    Obstet Gynecol; 1970 Oct; 36(4):589-96. PubMed ID: 5506464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics of bleeding when medroxyprogesterone, a depot progestogen is used].
    Rubio Lotvin B; González R
    Ginecol Obstet Mex; 1969 May; 24(151):503-7. PubMed ID: 5347656
    [No Abstract]   [Full Text] [Related]  

  • 10. Modifications of hormone excretion patterns after treatment with 6alpha-methyl-17alpha-acetoxyprogesterone and 17alpha-ethynyl-estradiol.
    Baldratti G; Casteguaro E
    Arzneimittelforschung; 1967 Oct; 17(10):1301-4. PubMed ID: 5632882
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction of ovulation in progestin-treated adult rats.
    Banik UK; Haltrecht I; Herr F
    Acta Endocrinol (Copenh); 1970 Apr; 63(4):747-52. PubMed ID: 5468290
    [No Abstract]   [Full Text] [Related]  

  • 12. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
    Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
    Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of injectable contraceptive immediately post partum.
    Jones JR; Lonky S
    N Y State J Med; 1971 Oct; 71(19):2279-82. PubMed ID: 5315289
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of hormonal contraception on bone mineral density after 24 months of use.
    Berenson AB; Breitkopf CR; Grady JJ; Rickert VI; Thomas A
    Obstet Gynecol; 2004 May; 103(5 Pt 1):899-906. PubMed ID: 15121563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medroxprogestrone acetate as a contraceptive].
    Hornemann B; Osler M
    Ugeskr Laeger; 1973 Feb; 135(6):289-94. PubMed ID: 4690433
    [No Abstract]   [Full Text] [Related]  

  • 16. [Medroxyprogesterone acetate in the control of fertility].
    Rubio Lotvin B; Gonzalez R; Litwak O; Bielak S
    Prensa Med Mex; 1969; 34(5):192-6. PubMed ID: 5386327
    [No Abstract]   [Full Text] [Related]  

  • 17. [Observations on the milk secretion-inhibiting action of an oral estro-progestin compound].
    Valsecchi A; Bailo U
    Minerva Ginecol; 1965 Sep; 17(18):934-5. PubMed ID: 5880592
    [No Abstract]   [Full Text] [Related]  

  • 18. [Contraception with the 3-months injection].
    Hauser GA
    Ther Umsch; 1972 May; 29(5):310-3. PubMed ID: 5064704
    [No Abstract]   [Full Text] [Related]  

  • 19. [Enzymohistochemical changes induced in the rat ovary by an association of 6 alpha-methyl-17 alpha-acetoxyprogesterone and 17 alpha-ethynyl estradiol].
    Turolla E; Gaetani M; Baldratti G
    Folia Endocrinol; 1967 Aug; 20(4):526-34. PubMed ID: 5631036
    [No Abstract]   [Full Text] [Related]  

  • 20. [The response of the human endometrium to endocrino-sexual stimuli. Experimental study].
    Cappello F; Tapparelli E
    Minerva Ginecol; 1968 Feb; 20(4):378-83. PubMed ID: 5738737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.